Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pepdoo is a biotechnology company specializing in the research, development, and large-scale production of bioactive peptides and collagen-based nutritional supplements. Based in Guangzhou, China, the company utilizes advanced enzymatic hydrolysis and purification technologies to create high-purity peptide ingredients for the food, beverage, cosmetic, and pharmaceutical industries. Their product portfolio includes fish collagen peptides, bovine collagen, and various plant-based peptides aimed at improving skin health, joint function, and metabolic wellness. Pepdoo operates as both a brand owner and a raw material supplier, providing CDMO services for functional food formulations. The company focuses on small-molecule peptides with high bioavailability for global health and wellness markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PEPDOO.